Want to shed half a stone in time for summer without jabs? Acupuncture could be the answer, experts claim

It's a development that gives a whole new meaning to the term 'fat jabs' – for scientists have found that a form of acupuncture may help women lose weight.
In a trial, those who received the needle treatment lost 3kg – or 6.6lb – more than those receiving a dummy, placebo procedure after 24 weeks.
They also lost more body fat, felt less hungry and saw their waists and hips shrink further.
Experts said the findings mean the procedure could offer another option for tackling obesity, particularly for those who cannot or do not want to take weight-loss drugs.
Currently, medicines such as Wegovy and Mounjaro are estimated to be used by around 2.5 million Britons.
The blockbuster jabs, known as GLP-1s, can help people lose around a fifth of their body weight after around 16 months.
In the new study, however, researchers from the Shanghai Municipal Hospital of Traditional Chinese Medicine looked at the effectiveness of a type of acupuncture known as acupoint thread embedding (ATE) for tackling obesity.
They recruited 132 women aged 18 to 45 who were overweight or obese, splitting them in two groups: half receiving ATE versus a procedure that mimicked the treatment.
In traditional acupuncture, needled are removed after each session (pictured)
ATE involves using a needle to place a short piece of dissolvable thread beneath the skin.
In the study, the threads were inserted into points on the abdomen, waist and legs.
Unlike traditional acupuncture, where needles are used and removed after each session, the thread remains in place and can take around six months to dissolve.
Researchers believe this may allow it to continue stimulating the body's hunger signals - making patients less hungry - long after treatment has ended.
Both groups attended six treatment sessions over 12 weeks and were also encouraged to improve their diet and exercise habits.
Participants in the placebo group wore masks so they could not see which treatment they received.
After 12 weeks, women who had the ATE treatment lost an average of 2.4kg – 5.3lb – compared with 0.6kg, or 1.3lb, in the placebo group.
Researchers then followed participants for a further 12 weeks after the treatment stopped.
While there was no exact figure published for total weight loss, the researchers said the ATE group had around a 3kg greater weight loss than those receiving placebo.
More women in the ATE group also lost at least 5 per cent of their body weight.
After 24 weeks, nearly a third of those who had the treatment managed it, compared with 10.6 per cent in the dummy group.
The ATE group also lost around 1.8 per cent more body fat than those in the placebo group after 12 weeks, rising to 2.8 per cent after 24 weeks.
Women given the treatment also saw larger reductions in waist size and hip size, with their waists and hips around 5cm smaller than the placebo group after six months.
They also reported lower levels of hunger.
Writing in the journal Annals of Internal Medicine, the authors said ATE 'produced modest but sustained reductions' in key measurements of excess body fat.
'These findings support ATE as a potential adjunctive weight-management strategy for selected persons who prefer or require nonpharmacologic options,' they added.
The team could not prove exactly how the treatment works, but offered some theories.
One, they suggested, is that ATE may suppress appetite where it is inserted, and that the thread may keep stimulating the body for months.
Furthermore, no serious side effects were reported. However, around one in ten women experienced pain around the treatment site.
The study team also acknowledged that the research had limitations.
This included that it was relatively small in size, only involved women and lasted just six months.
The researchers also said the weight loss was similar to that seen with some lifestyle changes, such as time-limited eating or exercise programmes.
They said larger studies are needed before the technique could be recommended more widely.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.